Skip to main content
CRBU
NASDAQ Life Sciences

Caribou's Allogeneic CAR-T Data Rivals Autologous Therapies; Q2 Results Show Cash Runway

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.62
Mkt Cap
$159.681M
52W Low
$1.38
52W High
$3.535
52W Position info
17% above low
Off High info
54% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

CRBU sits 17% above its 52-week low of $1.38.

Summary

Caribou reported Q2 2026 results alongside detailed EHA 2026 data for its two lead allogeneic CAR-T programs. Vispa-cel in 2L LBCL showed 82% ORR, 67% CR, and 17.1-month median PFS in the optimized subgroup (N=27), which the company says is on par with approved autologous therapies. CB-011 in r/r MM showed 92% ORR and 83% ≥CR in BCMA-naïve patients at the RDE, with 50% still in ≥CR at 15 months. The company also highlighted a case study of a heavily pretreated patient achieving CR after a single CB-011 dose. Financially, Caribou reported licensing revenue and reiterated a 12-month operating runway from the prior quarter. This follows the June 11 positive Phase 1 data release and adds granular efficacy numbers plus financials. The key upcoming catalyst is H2 2026 dose expansion data for CB-011 in >15 patients with ≥3 months follow-up.

At the time of this announcement, CRBU was trading at $1.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $159.7M. The 52-week trading range was $1.38 to $3.54. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CRBU - Latest Insights

CRBU
Nov 05, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.405
Real-time Price: $0.3195 info
Change: -$0.0855 (-21%) info
Market Cap: $35.231M info
CRBU
Nov 05, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.405
Real-time Price: $0.3195 info
Change: -$0.0855 (-21%) info
Market Cap: $35.231M info
CRBU
Oct 06, 2026, 4:37 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.705
Real-time Price: $0.3195 info
Change: -$0.3855 (-55%) info
Market Cap: $35.231M info
CRBU
Oct 06, 2026, 4:11 PM EDT
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.3195 info
Change: -$0.8155 (-72%) info
Market Cap: $35.231M info
CRBU
Oct 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.3195 info
Change: -$0.8155 (-72%) info
Market Cap: $35.231M info